Table 1.
Individual | Gene | Relative risk | Risk by age 70 | Cancer morphology | Other cancers | Reference(s) |
---|---|---|---|---|---|---|
No history | None | 1 | 0.5% | NS | None | |
Breast cancer | BRCA2 | 3.5–10X | 5% | NS | Breast, ovary, and prostate | (10, 11) |
BRCA1 | 2X | 1% | Breast cancer with basaloid features | Breast, ovary, and prostate | (12) | |
FAMMM | P16 (CDKN2A) | 20–34X | 10%–17% | NS | Melanoma | (14, 185) |
Familial pancreatic cancer (3 FDR) | Unknown | 32X | 16% | NS | Unknown | (9) |
Familial pancreatitis | PRSS1 | 50–80X | 25%–40% | Pancreatic cancers in the background of severe diffuse chronic pancreatitis | None | (17) |
Peutz-Jeghers | STK11/LKB1 | 132X | 30%–60% | NS | Gastroesophageal, small bowel, colorectal, and breast | (13, 16) |
HNPCC | hMLH1, hMSH2, others | Unknown | < 5% | Medullary and colloid phenotypes | Colorectal, endometrial, stomach, ovarian, ureter and renal pelvis, biliary tract, and brain | (18, 186) |
Young-age-onset pancreatic cancer | FANC-C and FANC-G | Unknown | Unknown | NS | Unknown | (187, 188) |
3 FDR, 3 or more first-degree relatives with pancreatic cancer; FAMMM, familial atypical multiple mole melanoma syndrome; HNPCC, hereditary nonpolyposis colorectal cancer syndrome; NS, nonspecific.